Application Information

This drug has been submitted to the FDA under the reference 205579/001.

Names and composition

"RYANODEX" is the commercial name of a drug composed of DANTROLENE SODIUM.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
205579/001 RYANODEX DANTROLENE SODIUM FOR SUSPENSION/INTRAVENOUS 250MG per VIAL

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
017443/001 DANTRIUM DANTROLENE SODIUM CAPSULE/ORAL 25MG
017443/002 DANTRIUM DANTROLENE SODIUM CAPSULE/ORAL 100MG
017443/003 DANTRIUM DANTROLENE SODIUM CAPSULE/ORAL 50MG
018264/001 DANTRIUM DANTROLENE SODIUM INJECTABLE/INJECTION 20MG per VIAL
076686/001 DANTROLENE SODIUM DANTROLENE SODIUM CAPSULE/ORAL 25MG
076686/002 DANTROLENE SODIUM DANTROLENE SODIUM CAPSULE/ORAL 50MG
076686/003 DANTROLENE SODIUM DANTROLENE SODIUM CAPSULE/ORAL 100MG
076856/001 DANTROLENE SODIUM DANTROLENE SODIUM CAPSULE/ORAL 25MG
076856/002 DANTROLENE SODIUM DANTROLENE SODIUM CAPSULE/ORAL 50MG
076856/003 DANTROLENE SODIUM DANTROLENE SODIUM CAPSULE/ORAL 100MG
078378/001 REVONTO DANTROLENE SODIUM INJECTABLE/INJECTION 20MG per VIAL
204762/001 DANTROLENE SODIUM DANTROLENE SODIUM INJECTABLE/INJECTION 20MG per VIAL
205239/001 DANTROLENE SODIUM DANTROLENE SODIUM INJECTABLE/INJECTION 20MG per VIAL
205579/001 RYANODEX DANTROLENE SODIUM FOR SUSPENSION/INTRAVENOUS 250MG per VIAL

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved